Basic Information
Basic information for AC022034.3-212-33aa-1
Peptide Name AC022034.3-212-33aa-1
Genome Position chr8:53395213-53395222,53395978-53396066[-]
Species Human
Peptide Sequence MQDRDHGSWARLDEIWGSLEVENVFALGKRGDV
Peptide Length 33
Unique No (AC022034.3-219-33aa-1,AC022034.3-202-33aa-2,AC022034.3-222-33aa-2,AC022034.3-204-33aa-1,AC022034.3-217-33aa-1,AC022034.3-210-33aa-2,AC022034.3-211-33aa-1,AC022034.3-214-33aa-1,AC022034.3-205-33aa-2,AC022034.3-201-33aa-2,AC022034.3-218-33aa-2)
Grand Average of Hydropathicity -0.6152
Relative Molecular Mass 4363.62
Experimental Evidences no
lncRNA ID/Name ENSG00000253369;AC022034.3
Transcript ID/Name ENST00000653042;AC022034.3-212
Transcript Length 1335
Coding Ability 0.5191
DNA Sequence Corresponding to Peptide ATGCAGGACAGAGATCATGGAAGTTGGGCCCGACTGGATGAGATTTGGGGGTCTTTGGAAGTGGAGAATGTGTTTGCCCTGGGGAAGAGAGGTGATGTC
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :